Prevention of Insulin-Induced Hypoglycemia in Type 1 Diabetes with Predictive Low Glucose Management System
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Sensor-augmented pump therapy (SAPT) with algorithms to predict impending low blood glucose and suspend insulin delivery has the potential to reduce hypoglycemia exposure. The aim of this study was to determine whether predictive low glucose management (PLGM) system is effective in preventing insulin-induced hypoglycemia in controlled experiments. METHODS: Two protocols were used to induce hypoglycemia in an in-clinic environment. (A) Insulin bolus: Insulin was administered as a manual bolus through the pump. (B) Increased basal insulin: Hypoglycemia was induced by increasing basal rates overnight to 180%. For both protocols, participants were randomized and studied on 2 separate days; a control day with SAPT alone and an intervention day with SAPT and PLGM activated. The predictive algorithm was programmed to suspend basal insulin infusion when sensor glucose was predicted to be <80 mg/dL in 30 min. The primary outcome was the requirement for hypoglycemia treatment (symptomatic hypoglycemia or plasma glucose <50 mg/dL) and was compared in both control and intervention arms. RESULTS: With insulin bolus, 24/28 participants required hypoglycemia treatment with SAPT alone compared to 5/28 participants when PLGM was activated (P ≤ 0.001). With increased basal rates, all the eight SAPT-alone participants required treatment for hypoglycemia compared to only one with SAPT and PLGM. There was no post pump-suspend hyperglycemia with insulin bolus (P = 0.4) or increased basal rates (P = 0.69) in participants with 2-h pump suspension on intervention days. CONCLUSIONS: SAPT with PLGM reduced the requirement for hypoglycemia treatment following insulin-induced hypoglycemia in an in-clinic setting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Threshold-based insulin-pump interruption for reduction of hypoglycemia
Bergenstal, R. M., Klonoff, D. C., Garg, S. K., Bode, B. W., Meredith, M., Slover, R. H., Ahmann, A. J., Welsh, J. B., Lee, S. W., & Kaufman, F. R. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303576 · Cited by 652 · cited 1×
“This function reduces moderate and severe episodes of hypoglycemia in patients with impaired awareness of hypoglycemia(6) and suspension of insulin delivery is not associated with rebound hyperglycemia and ketosis or significant changes in glycated hemoglobin.(7,8) The development of an algorithm that predicts impendi…”
Ly, T. T., Nicholas, J. A., Retterath, A., Lim, E. M., Davis, E. A., & Jones, T. W. (2013) · JAMA · doi:10.1001/jama.2013.277818 · Cited by 411 · cited 1×
“4,5 This function reduces moderate and severe episodes of hypoglycemia in patients with impaired awareness of hypoglycemia 6 and suspension of insulin delivery is not associated with rebound hyperglycemia and ketosis or significant changes in glycated hemoglobin.”
Self-citationFear of hypoglycaemia in parents of young children with type 1 diabetes: A systematic review
Barnard, K., Thomas, S., Royle, P., Noyes, K., & Waugh, N. (2010) · BMC Pediatrics · doi:10.1186/1471-2431-10-50 · Cited by 239 · cited 1×
“Fear of hypoglycemia experienced by the patient or caregiver detrimentally affects quality of life and leads to hypoglycemia avoidance behaviors that promote hyperglycemia and the associated risk of long-term diabetes complications.(3)”
Tanenberg, R. J., Newton, C. A., & Drake, A. J. (2010) · Endocrine Practice · doi:10.4158/ep09260.cr · Cited by 225 · cited 1×
“The symptoms of hypoglycemia are distressing and, if prolonged, these episodes can lead to seizures, coma, and even death.(1,2) Fear of hypoglycemia experienced by the patient or caregiver detrimentally affects quality of life and leads to hypoglycemia avoidance behaviors that promote hyperglycemia and the associated…”
Insulin Pump Therapy With Automated Insulin Suspension in Response to Hypoglycemia
Choudhary, P., Shin, J., Wang, Y., Evans, M. L., Hammond, P. J., Kerr, D., Shaw, J. A. M., Pickup, J. C., & Amiel, S. A. (2011) · Diabetes Care · doi:10.2337/dc10-2411 · Cited by 175
Prevention of Nocturnal Hypoglycemia Using Predictive Alarm Algorithms and Insulin Pump Suspension
Buckingham, B., Chase, H. P., Dassau, E., Cobry, E., Clinton, P., Gage, V., Caswell, K., Wilkinson, J., Cameron, F., Lee, H., et al. (2010) · Diabetes Care · doi:10.2337/dc09-2303 · Cited by 169 · cited 1×
“Linear prediction and statistical prediction models were used to prevent hypoglycemia in the day studies,(9) while a combination of algorithms using a voting scheme was used for the night studies to manually suspend the pump.(10) This was followed by a pilot and larger randomized home trial, using a laptop-based Kalma…”
MethodSelf-citationGarg, S., Brazg, R. L., Bailey, T. S., Buckingham, B. A., Slover, R. H., Klonoff, D. C., Shin, J., Welsh, J. B., & Kaufman, F. R. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0292 · Cited by 138 · cited 1×
“detected hypoglycemia thereby reducing the duration of hypoglycemia.(4,5) This function reduces moderate and severe episodes of hypoglycemia in patients with impaired awareness of hypoglycemia(6) and suspension of insulin delivery is not associated with rebound hyperglycemia and ketosis or significant changes in glyca…”
Cited by
Cappon, G., Vettoretti, M., Sparacino, G., & Facchinetti, A. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0121 · Cited by 477
Lorenz, C., Sandoval, W., & Mortellaro, M. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0028 · Cited by 80
“C linical use of continuous glucose monitoring ( CGM) systems is associated with reduced hemoglobin A1c values, 1–3 decreased exposure to hypoglycemia, 4,5 reduced glycemic variability, 6 and enhanced convenience and quality of life.”
Beato-Víbora, P. I., Quirós-López, C., Lázaro-Martín, L., Martín-Frías, M., Barrio-Castellanos, R., Gil-Poch, E., Arroyo-Díez, F. J., & Giménez-Álvarez, M. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0199 · Cited by 60
“Baseline Hb A1c , using the average of the last two values, and Hb A1c at 6, 12, 18, and 24 months were registered.”
Lucidi, P., Porcellati, F., Bolli, G. B., & Fanelli, C. G. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1065-6 · Cited by 38
Fear of hypoglycemia and sleep in children with type 1 diabetes and their parents
Schierloh, U., Aguayo, G. A., Fichelle, M., De Melo Dias, C., Schritz, A., Vaillant, M., Barnard-Kelly, K., Cohen, O., Gies, I., & de Beaufort, C. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1419502 · Cited by 7
Metadata
- Authors
- Abraham, M. B., de Bock, M., Paramalingam, N., O'Grady, M. J., Ly, T. T., George, C., Roy, A., Spital, G., Karula, S., Heels, K., Gebert, R., Fairchild, J. M., King, B. R., Ambler, G. R., Cameron, F., Davis, E. A., & Jones, T. W.
- Venue
- Diabetes Technology & Therapeutics
- Publisher
- SAGE Publications
- Published
- 2016-07
- Volume
- 18
- Issue
- 7
- Pages
- 436-443
- ISSN
- 1520-9156 (ISSN-L)
- 1557-8593
- OpenAlex
- W2346962338
- Cited by
- 34
- References
- 7
- FWCI
- 6.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.